A
Adaptimmune Therapeutics plc
ADAP
1.27000
USD
-0.05
(-3.79%)
مفتوح الان
حجم التداول
15,706
الربح لكل سهم
0
العائد الربحي
0
P/E
-2
حجم السوق
206,028,530
الأخبار
العنوان: Adaptimmune Therapeutics plc
القطاع: Healthcare
الصناعة: Biotechnology
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.